Skip to main content
. 2023 Jul 15;201(2):329–338. doi: 10.1007/s10549-023-07016-9

Table 4.

The distribution of molecular subtypes among “pure” DCIS and DCIS with an invasive component, according to the IHC surrogate markers, calculated and classified in the manner of 2013 St. Gallen recommendations

Subtypes Luminal A Luminal B HER2-negative Luminal B HER2-positive HER2-enriched TPN
n = 357 (100%) n = 127 n = 53 n = 79 n = 78 n = 20
Percentage of all 35.6 14.8 22.1 21.8 5.6 100
Percentage of “pure” DCIS 87 90 89 77 90 86
Percentage of DCIS w/invasion 13 10 11 23 10 14